跳至主要内容
临床试验/NCT00499941
NCT00499941已完成不适用

Alpha-1 Foundation Research Registry

Medical University of South Carolina1 个研究点 分布在 1 个国家目标入组 6,655 人开始时间: 2000年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6,655
试验地点
1
主要终点
To study the natural history of PiZZ, PiSZ, and PiMZ alpha-1 antitrypsin deficiency

研究概览

简要总结

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

详细描述

The Registry was established in 1997 by the Alpha-1 Foundation to facilitate research initiatives and promote the development of improved treatments and a cure for Alpha-1. Located at the Medical University of South Carolina (MUSC) in Charleston, the Registry employs procedures that ensure the most stringent confidentiality of participants. The Registry operates under the direction of the Alpha-1 Foundation Board of Directors and is guided by an Advisory Committee comprised of leaders in the medical, ethical, scientific and Alpha communities. Individuals enrolled in the Registry have the ongoing opportunity to participate directly in clinical trials of new therapeutic approaches in addition to other research opportunities.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Individuals of all ages who are diagnosed with severe alpha-1 antitrypsin deficiency or the carrier state

排除标准

  • 未提供

结局指标

主要结局

To study the natural history of PiZZ, PiSZ, and PiMZ alpha-1 antitrypsin deficiency

时间窗: Not limited

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Charlie Strange

Professor of Pulmonary and Critical Care Medicine

Medical University of South Carolina

研究点 (1)

Loading locations...

相似试验